Zurich, Zurich, Switzerland
Global healthcare leader with 15+ years of international experience across biopharma, management consulting, and biotech entrepreneurship. Track record of shaping global product, commercial, and portfolio strategies that drive local execution, high‑value partnerships, and asset and franchise success. Deep experience spanning commercial strategy, external innovation, partnerships, M&A, and organizational transformation. Trusted leader known for structuring complex, ambiguous challenges, aligning cross‑functional teams across R&D, commercial, digital, and regions, and delivering results at scale. MBA (Honors), IMD Business School; B.A., University of St. Gallen. Views expressed are my own and do not reflect those of my employer.
Shaping global commercial strategies in neuroscience. Accountable for diagnosis, digital, and patient services strategies for late-stage neuroscience pipeline programs
Management Consulting in the Pharma & Life Sciences industry, focusing on Strategy and Transformation initiatives. Selected projects (2016-2020): - Led a project bridging leading academic institutions and hospitals to found a new Medical Research Center for Precision Medicine - Led a project on a group digital strategy for a Big Pharma client - Advised a European health authority on strengthening biomedical research conditions - Advised on the execution of an operational carve-out of a global pharma business unit involving 500+ stakeholders, as the right hand of the carve-out lead
Leadership development program with a strong emphasis on entrepreneurship, globalization, and digitalization. Client projects during the MBA: - Social media enabled patient journey for a multinational pharmaceutical company - Go-to-market strategy for a Swiss medtech company in orthopaedics
Mergers and acquisitions (M&A) advisory and strategy consulting firm, focused on mid-market transactions in the biotech, pharmaceutical and medical technology industries. Kurmann Partners was taken over by EY in 2019, and used to be the exclusive Swiss member of IMAP, the largest global organization of independent M&A firms Selected projects: - Supported a specialty pharma company in acquiring global product rights - Advised a public pharma company on their M&A strategy to enter new markets in Europe - Advised on a sell-side project for a multinational consumer goods company
Travels through Latin America, Oceania, Africa and East Asia (several local projects)